Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

JUBILANT GENERICS

  • FDA Approval
  • Oct. 04, 2024, 04:05 UTC
  • 50
  • 0 comments

FDA approve SOLIFENACIN SUCCINATE

Comment Full text

MSN LABORATORIES PRIVATE LTD

  • FDA Approval
  • Oct. 03, 2024, 18:44 UTC
  • 47
  • 0 comments

FDA approve NILOTINIB

Comment Full text

DR REDDYS

  • FDA Approval
  • Oct. 03, 2024, 08:47 UTC
  • 44
  • 0 comments

FDA approve VARENICLINE TARTRATE

Comment Full text

MSN

  • FDA Approval
  • Oct. 03, 2024, 08:47 UTC
  • 45
  • 0 comments

FDA approve NEBIVOLOL HYDROCHLORIDE

Comment Full text

ACELLA

  • FDA Approval
  • Oct. 03, 2024, 08:47 UTC
  • 45
  • 0 comments

FDA approve PHENYTOIN SODIUM

Comment Full text

ALEMBIC

  • FDA Approval
  • Oct. 03, 2024, 08:47 UTC
  • 46
  • 0 comments

FDA approve LAMOTRIGINE

Comment Full text

ZHEJIANG JUTAI PHARM

  • FDA Approval
  • Oct. 03, 2024, 08:47 UTC
  • 48
  • 0 comments

FDA approve BUPROPION HYDROCHLORIDE

Comment Full text

BAXTER HLTHCARE CORP

  • FDA Approval
  • Oct. 03, 2024, 04:16 UTC
  • 50
  • 0 comments

FDA approve ERIBULIN MESYLATE

Comment Full text

HIKMA

  • FDA Approval
  • Oct. 02, 2024, 08:49 UTC
  • 52
  • 0 comments

FDA approve FUROSEMIDE

Comment Full text

AM REGENT

  • FDA Approval
  • Oct. 02, 2024, 08:49 UTC
  • 49
  • 0 comments

FDA approve FUROSEMIDE

Comment Full text
  • Previous
  • 338
  • 339
  • 340
  • 341
  • 342
  • Next

Search

News categories

  • Technical Exchange News(11504)
  • Event(3373)
  • SEC News(216327)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137460)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin